Clinical Progression of Breast Cancer Malignant Behavior: What to Expect and When to Expect it

Abstract

Breast cancer metastagenicity and virulence are heterogeneous even within clinically similar groups of operable breast cancer patients. Tumor progression is correlated with increasing tumor size and nodal involvement. Markers are needed to identify individual tumor virulence and metastagenicity.